Business Context and Reporting Period
This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp) on October 30, 2019. The filing announces the company's financial results for the quarter ended September 30, 2019. The company is incorporated in Nevada and trades on the Nasdaq Capital Market under the symbol EKSO.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Item 2.02 states that the full text of the press release containing these results is attached as Exhibit 99.1 and incorporated by reference, but the data itself is not present in the provided document text.
Material Changes
No material changes or comparative financial data versus the prior period are detailed in the provided text. The document serves solely as a notification that results have been reported and directs readers to the attached press release for details.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It explicitly notes that the information furnished in this report and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the Press Release dated October 30, 2019), as they are absent from the 8-K text.
- Confirm the company name is Ekso Bionics Holdings, Inc., noting the discrepancy with the "Chronoscale Holdings Corp" label in the request metadata.
- Check the Nasdaq Capital Market listing status and ticker symbol EKSO for any trading halts or updates following the report date.
- Review the full press release for any non-GAAP reconciliations or specific operational updates regarding their robotic exoskeleton products.